Cognitive Impairment in Lewy Body Dementia

Lewy body dementia is characterised by progressive cognitive decline underpinned by the accumulation of alpha-synuclein aggregates in cortical and subcortical neurons. Core features include fluctuating attention and alertness, visuospatial and executive dysfunction, preserved procedural memory in early stages, and prominent visual hallucinations often accompanied by parkinsonian motor signs. Pathophysiological changes involve cholinergic deficits, altered large-scale brain network dynamics with relative sparing of the default mode network, and microstructural white matter disruptions. Clinically, cognitive fluctuations may present as abrupt changes in performance, complicating differential diagnosis from Alzheimer’s disease and Parkinson’s disease dementia. The global burden of this condition emphasises the need for accurate biomarkers, sensitive neuropsychological tests and targeted therapeutic strategies to improve patient outcomes and alleviate healthcare costs.

Research from Nature Portfolio

Recent advances have leveraged machine-learning techniques to enhance diagnostic accuracy. A multimodal algorithm combining demographic, clinical and MRI measures achieved nearly 98 % discrimination between Alzheimer’s disease, frontotemporal dementia, Lewy body dementia and healthy controls. By integrating volumetric data, diffusion metrics and standardised staging instruments within a support vector machine framework, the model delivered high precision and recall. Importantly, explainable AI methods revealed the most informative features—such as thalamic volume and white matter integrity—facilitating clinical interpretability. This approach holds promise for cost-effective, early and objective diagnosis in routine practice.

Cognitive Impairment in Lewy Body Dementia publication trend

The graph below shows the total number of articles in cognitive impairment in lewy body dementia across all publications each year (not limited to Nature Index journals).

Technical terms

Lewy body: Intracellular aggregate of misfolded alpha-synuclein protein within neurons.

Diffusion tensor imaging: MRI technique that quantifies the directional movement of water to map white matter tracts and assess microstructural integrity.

Visuoconstruction: The capacity to organise and reproduce spatial relationships during drawing or assembly tasks.

Functional connectivity: Statistical measure of coordinated activity between distinct brain regions, typically assessed via resting-state fMRI.

Support Vector Machine: Supervised learning model that classifies data by finding the optimal hyperplane separating different categories.

References

1. A systematic review of diffusion tensor imaging and tractography in dementia with Lewy bodies and Parkinson’s disease dementia. Neuroscience & Biobehavioral Reviews (2025).
2. Visual dysfunction in dementia with Lewy bodies. Current Neurology and Neuroscience Reports (2024).
3. Differential diagnosis of neurodegenerative dementias with the explainable MRI based machine learning algorithm MUQUBIA. Scientific Reports (2023).
4. Functional connectivity in dementia with Lewy bodies: A within‐ and between‐network analysis. Human Brain Mapping (2017).
5. fMRI resting state networks and their association with cognitive fluctuations in dementia with Lewy bodies. NeuroImage Clinical (2014).